Eagle Health Investments’s Seagen Inc. Common Stock SGEN Stock Holding History

Eagle Health Investments’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-174,902	Closed	-$35.4M	–	32
2023 Q1	$35.4M	Hold	174,902	–	–	6.89%	5
2022 Q4	$22.5M	Hold	174,902	–	–	5.19%	13
2022 Q3	$23.9M	Sell	174,902 -87,600	-33%	-$14.3M	5.49%	8
2022 Q2	$46.4M	Buy	262,502 +32,000	+14%	+$4.61M	10.83%	1
2022 Q1	$33.2M	Buy	230,502 +150,002	+186%	+$20.3M	8.18%	2
2021 Q4	$12.4M	Buy	+80,500	New	+$13.5M	3.03%	18

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Eagle Health Investments's SGEN Position: Q2 2023 in Review

Eagle Health Investments sold out of Seagen Inc. Common Stock (SGEN) in Q2 2023, closing a stake of 174,902 shares — an estimated $35.4M sold.

Eagle Health Investments first reported a position in SGEN in Q4 2021 and held it in 6 quarters. The position peaked at $46.4M in Q2 2022. 594 funds tracked by Wall St. Rank hold SGEN as of Q2 2023.

Eagle Health Investments reported no remaining Seagen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Eagle Health Investments sold 174,902 Seagen Inc. Common Stock shares in Q2 2023, an estimated $35.4M.
Eagle Health Investments first reported a position in Seagen Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Eagle Health Investments's Seagen Inc. Common Stock position peaked at $46.4M in Q2 2022.
594 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2023.

Based on Eagle Health Investments's 13F filing for Q2 2023, filed 14 Aug 2023.